Welcome to our dedicated page for Radnet news (Ticker: RDNT), a resource for investors and traders seeking the latest updates and insights on Radnet stock.
RadNet, Inc. (NASDAQ: RDNT) generates a steady flow of news as a national provider of freestanding, fixed-site diagnostic imaging services and as the parent of DeepHealth, its AI-powered health informatics division. News about RadNet often highlights developments across its network of 407 owned and/or operated outpatient imaging centers in markets such as Arizona, California, Delaware, Florida, Maryland, New Jersey, New York and Texas, as well as updates from its Digital Health segment.
Investors and observers following RDNT news will encounter announcements on topics such as acquisitions of imaging centers, expansion into new regional markets and updates on RadNet’s operational performance. For example, the company has reported acquisitions like Radiology Regional in Southwest Florida, adding multiple imaging centers and staff to its Florida footprint. Earnings releases and financial guidance updates are also frequent news items, reflecting trends in imaging volumes, segment revenue and Adjusted EBITDA for both the Imaging Center and Digital Health segments.
RadNet’s DeepHealth division is another major source of news, with press releases covering the launch of AI-powered clinical suites, imaging informatics platforms and collaborations with partners. Recent communications have described products such as Breast Suite, Thyroid Suite, Operations Suite, Diagnostic Suite and TechLive, as well as research findings published in scientific journals and showcased at industry conferences like RSNA. News may also cover strategic collaborations, including letters of intent and partnerships with companies such as GE HealthCare to expand AI-powered imaging solutions across modalities and geographies.
Because RadNet regularly issues updates on its financial results, acquisitions, digital health initiatives and research milestones, the RDNT news page can be a useful resource for tracking how the company’s imaging center operations and DeepHealth portfolio evolve over time. Readers interested in diagnostic imaging services, AI in radiology and healthcare operations technology may find RadNet’s news particularly relevant.
RadNet (NASDAQ: RDNT), a national leader in diagnostic imaging services, has announced its participation in the upcoming 35th Annual Oppenheimer Healthcare MedTech & Services Conference. The company's Executive Vice President and Chief Executive Officer, Mark Stolper, will deliver a virtual presentation on March 17, 2025, at 12:40 p.m. Eastern Time.
The presentation will be accessible through a live webcast at wsw.com/webcast/oppenheimer40/rdnt/2795776, with replay options available. RadNet operates a network of fully-owned and operated outpatient imaging centers, focusing on providing high-quality, cost-effective diagnostic imaging services.
RadNet (NASDAQ: RDNT) reported strong Q4 2024 financial results with record-breaking performance. Total revenue increased 13.5% to $477.1 million, while Adjusted EBITDA grew 14.0% to $75.0 million compared to Q4 2023. The Digital Health segment showed impressive growth with revenue up 28.1% to $18.9 million.
Key operational highlights include:
- 8.0% increase in aggregate procedural volumes
- 4.0% growth in same-center procedural volumes
- Strong imaging volume growth: MRI +13.4%, CT +13.9%, PET/CT +23.9%
- Expansion to 398 imaging centers, with 38.4% being joint venture facilities
The company maintained a strong financial position with $740 million cash balance and net debt to Adjusted EBITDA ratio under 1.0x. Adjusted Earnings Per Share reached $0.22 in Q4 2024, up from $0.15 in Q4 2023.
RadNet (NASDAQ: RDNT) has announced a strategic partnership with OB/GYN Specialists of the Palm Beaches to launch breast imaging services across multiple locations in Palm Beach County. The collaboration integrates RadNet's DeepHealth AI-powered diagnostic solutions with OB/GYN Specialists, the largest obstetric and gynecological care provider in the region serving 60,000 women annually across 10 locations.
The partnership features RadNet's Enhanced Breast Cancer Detection (EBCD) protocol, which has demonstrated a 21% increase in breast cancer detection rates. The service includes interpretation by RadNet's board-certified breast imaging radiologists and implements DeepHealth's AI-driven health informatics, featuring cloud-based operating systems, patient tracking, and risk assessment integrated with EHR systems.
DeepHealth, a subsidiary of RadNet (NASDAQ: RDNT), will showcase new AI-powered radiology solutions at ECR 2025 in Vienna. The company will introduce Diagnostic Suite™, a cloud-native PACS alternative, and SmartMammo™, an AI-powered mammography solution that has shown a 21% increase in cancer detection rate.
The company's AI-powered Lung solution is currently supporting the NHS England's Lung Cancer Screening Program, where 76% of cancers were detected at earlier stages, compared to 29% historically. Their Prostate solution has demonstrated 97% diagnostic sensitivity and 37% reduction in workflow time for MRI reads.
DeepHealth's solutions are powered by DeepHealth OS, a cloud-native operating system integrating data across various platforms. The company's technology is currently utilized by over 800 clinical sites and more than 3,000 radiologists globally.
RadNet's subsidiary DeepHealth and ConcertAI's TeraRecon announced a strategic collaboration to advance imaging tools and radiology workflow. The partnership will integrate TeraRecon's advanced visualization technology into DeepHealth OS cloud-native Operating System, while incorporating DeepHealth's clinical AI solutions into TeraRecon's AI ecosystem.
The collaboration aims to create a seamless AI-enabled diagnostic experience for radiologists through DeepHealth's Diagnostic Suite™, enhancing diagnostic accuracy and efficiency. As imaging volumes rise, these integrated AI-powered solutions will help radiology departments manage workload while maintaining precision.
Both companies will explore additional areas to integrate AI-driven imaging and workflow automation, potentially including DeepHealth's AI-powered cancer screening capabilities in TeraRecon's ecosystem. The partnership will be showcased at the European Congress of Radiology 2025 in Vienna from February 26 to March 2.
RadNet (NASDAQ: RDNT), a national leader in diagnostic imaging services, has scheduled its fourth quarter 2024 financial results conference call for Friday, February 28, 2024 at 7:30 a.m. Pacific Time (10:30 a.m. Eastern Time). Investors can participate by dialing 844-826-3035 (US) or 412-317-5195 (International). The company will provide simultaneous and archived webcasts of the call, accessible through their dedicated webcast platform. An archived replay will be available via phone using the passcode 10197109.
RadNet (NASDAQ: RDNT), a leading provider of outpatient diagnostic imaging services, has announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco. The presentation will take place on Wednesday, January 15th, 2025, at 3:00 p.m. PST at The Westin St. Francis Hotel.
Key executives participating in the presentation include Dr. Howard Berger (President and CEO), Mark Stolper (EVP and CFO), and Dr. Gregory Sorensen (EVP and Chief Science Officer). The presentation will be available via live webcast and can be accessed through the provided link for replay viewing.
DeepHealth, a subsidiary of RadNet (RDNT), has chosen Ketryx to accelerate its AI-powered health informatics solutions development. The partnership aims to streamline radiology workflows and enhance care delivery through DeepHealth's cloud-native operating system. According to FDA data, 79% of newly approved devices in radiology utilize AI/ML technologies.
DeepHealth will leverage Ketryx's connected lifecycle management software to accelerate product development while maintaining quality and compliance. The integration with tools like Jira and GitLab enables automated documentation and end-to-end traceability, helping expedite innovative product releases while adhering to regulatory requirements.
RadNet (NASDAQ: RDNT), a leading provider of diagnostic imaging services, has announced its participation in the BofA Securities 2024 Leveraged Finance Conference. Mark Stolper, Executive Vice President and CFO, will present at the conference in Boca Raton, FL on December 3, 2024, at 8:10 a.m. Eastern Time (5:10 a.m. Pacific Time).
The presentation will be accessible through simultaneous and archived webcasts available on both the BofA conference platform and RadNet's corporate website under the 'About RadNet' section and 'News and Press Releases' sub-menu.
DeepHealth, RadNet's subsidiary, launches new AI-powered solutions at RSNA 2024, including the cloud-native DeepHealth OS, Diagnostic Suite™, and TechLive™. The company introduces SmartTechnology™ solutions, featuring SmartMammo™ and SmartSonography™, developed in collaboration with GE HealthCare and Siemens Healthineers. These innovations aim to enhance imaging-based diagnosis, population health screening, and operational efficiency. The company has established strategic partnerships with industry leaders including CARPL.ai, TeraRecon, and Google to scale these solutions. Currently, DeepHealth's solutions are utilized by over 800 clinical sites and 3,000 radiologists worldwide.